Literature DB >> 29982486

Dual-organ transplantation in older recipients: outcomes after heart-kidney transplant versus isolated heart transplant in patients aged ≥65 years.

Heidi Reich1,2, Sadia Dimbil1, Ryan Levine1, Dominick Megna1,2, Savannah Mersola1, Jignesh Patel1, Michelle Kittleson1, Lawrence Czer1, Jon Kobashigawa1, Fardad Esmailian1,2.   

Abstract

OBJECTIVES: Combined heart-kidney transplantation has successful outcomes. With an increasing number of patients with end-stage heart disease, there is a high incidence of significant renal insufficiency that may necessitate combined heart-kidney transplant. Outcomes for heart-kidney transplant recipients aged ≥65 years are not well described.
METHODS: Between 2010 and 2015, 163 recipients ≥65 years of age were transplanted in a single centre: 12 heart-kidney and 151 isolated heart transplants. Outcomes assessed were estimated glomerular filtration rate at 1, 6 and 12 months after transplant, the need for dialysis, 1-year survival, 1-year freedom from rejection, 1-year freedom from cardiac allograft vasculopathy and 1-year freedom from non-fatal major adverse cardiac events.
RESULTS: Recipient ages were 67.8 ± 1.6 and 69.0 ± 2.8 years for heart-kidney transplant and isolated heart transplant, and pretransplant estimated glomerular filtration rates were 26.6 ± 9.4 vs 55.2 ± 18.9, respectively. At 1 month (66.3 ± 31.4 vs 67.2 ± 28.0, P = 0.92), 6 months (68.1 ± 21.3 vs 60.5 ± 19.6, P = 0.20) and 12 months (58.6 ± 21.5 vs 52.4 ± 18.5, P = 0.27) post-transplant, estimated glomerular filtration rate was similar for heart-kidney transplant versus isolated heart transplant. There was a trend towards reduced 1-year freedom from temporary dialysis after heart-kidney transplant relative to isolated heart transplant (75.0% vs 90.4%, P = 0.06) without a difference in 1-year freedom from chronic dialysis (100% vs 95.2%, P = 0.46). There were no differences in 1-year survival, 1-year freedom from any treated rejection, acute cellular rejection, antibody-mediated rejection, cardiac allograft vasculopathy and non-fatal major adverse cardiac events.
CONCLUSIONS: For patients ≥65 years old, heart-kidney transplant can achieve outcomes on par with heart transplant alone.

Entities:  

Mesh:

Year:  2019        PMID: 29982486     DOI: 10.1093/icvts/ivy202

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  3 in total

Review 1.  Cardiorenal syndrome: Multi-organ dysfunction involving the heart, kidney and vasculature.

Authors:  Feby Savira; Ruth Magaye; Danny Liew; Christopher Reid; Darren J Kelly; Andrew R Kompa; S Jeson Sangaralingham; John C Burnett; David Kaye; Bing H Wang
Journal:  Br J Pharmacol       Date:  2020-05-13       Impact factor: 8.739

2.  Incidence of end-stage renal disease after heart transplantation and effect of its treatment on survival.

Authors:  Stefan Roest; Dennis A Hesselink; Dominika Klimczak-Tomaniak; Isabella Kardys; Kadir Caliskan; Jasper J Brugts; Alexander P W M Maat; Michał Ciszek; Alina A Constantinescu; Olivier C Manintveld
Journal:  ESC Heart Fail       Date:  2020-02-05

Review 3.  Combined Heart-Kidney Transplantation: Indications, Outcomes, and Controversies.

Authors:  Syed Adeel Ahsan; Ashrith Guha; Juan Gonzalez; Arvind Bhimaraj
Journal:  Methodist Debakey Cardiovasc J       Date:  2022-09-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.